Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Christopher M, Saddler"'
Autor:
Hanna L. Kleiboeker, PharmD, BCTXP, Jillian L. Descourouez, Emily M. Garcia, Olivia G. Huber, Ravi Dhingra, Erin Lowery, Didier A. Mandelbrot, MD, Jeannina A. Smith, Christopher M. Saddler, Margaret R. Jorgenson
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100063- (2024)
Despite the availability of potent antiviral therapy and increasingly long prophylaxis courses, cytomegalovirus (CMV) infection continues to negatively affect outcomes after cardiothoracic transplant (CT). CMV antiviral stewardship (AVS) represents a
Externí odkaz:
https://doaj.org/article/31efc6f43e5443fd97e9fc137cc84a39
Autor:
Ting Zhang, MD, Michael Christopher, MD, Natasha M. Simske, BS, Christopher M. Saddler, MD, Thomas Keenan, MD, Paul S. Whiting, MD
Publikováno v:
OTA International, Vol 3, Iss 3, p e082 (2020)
Abstract. The authors present the case of a patient who developed an Aspergillosis flavus (A flavus) superficial cutaneous infection which was identified at the time of cast removal, 2 weeks after immobilization of a closed distal third humerus fract
Externí odkaz:
https://doaj.org/article/00befcf5b4de45539bbd981cf2c76ff2
Autor:
Neetika Garg, Margaret Jorgenson, Jillian Descourouez, Christopher M. Saddler, Sandesh Parajuli, Brad C. Astor, Arjang Djamali, Didier Mandelbrot
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background The goal of this study was to identify predictors for development of Pneumocystis jirovecii pneumonia (PJP) in kidney and simultaneous kidney and pancreas transplant recipients in the present era of universal primary prophylaxis.
Externí odkaz:
https://doaj.org/article/5e6e22d5536e4ac1bec0f6f1e30fcb6e
Autor:
Margaret R, Jorgenson, Jillian L, Descourouez, Lucas T, Schulz, Christopher M, Saddler, Jeannina A, Smith
Publikováno v:
Current Opinion in Organ Transplantation. 28:8-14
Despite the availability of potent antivirals, consensus guidelines and decades of research, cytomegalovirus (CMV) continues to be associated with negative outcomes after solid organ transplant. This has been attributed to postprophylaxis CMV infecti
Autor:
Hanna L. Kleiboeker, Jillian L. Descourouez, Lucas T. Schulz, Didier A. Mandelbrot, Jon S. Odorico, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, Margaret R. Jorgenson
Publikováno v:
Annals of Pharmacotherapy. 57:597-608
Objective: To review the efficacy and safety of maribavir for management of cytomegalovirus (CMV) in solid organ transplant recipients. Data Sources: A literature search of PubMed and the Cochrane Controlled Trials Register (1960 to early July 2022)
Autor:
Emily Zona, Margaret Jorgenson, Sonam Dolma, Angelie Santos, Neetika Garg, Fahad Aziz, Maha Mohamed, Christopher M. Saddler, Jeannina A. Smith, Didier Mandelbrot, Sandesh Parajuli
Publikováno v:
Clinical Transplantation.
Autor:
Margaret R. Jorgenson, Hanna L. Kleiboeker, Brad C. Astor, Amy C. Gentry, Christopher M. Saddler, Jeannina A. Smith, Fahad Aziz, Didier Mandelbrot, Neetika Garg
Publikováno v:
Clinical transplantationREFERENCES.
Studies conducted in the northern United States found cytomegalovirus (CMV) disease after liver transplantation follows a seasonal pattern, with increased incidence in fall and winter. This has not been evaluated in kidney transplant recipients. Impr
Autor:
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra
Publikováno v:
Transplant Infectious Disease. 24
To evaluate epidemiology, risk-factors, and outcomes of high-level (HL) cytomegalovirus (CMV) viremia in liver transplant recipients.Adult patients receiving a liver transplant between 1/1/2017 and 9/30/2020 were evaluated. Viral loads at University
Autor:
Margaret R. Jorgenson, Jillian L. Descourouez, Hanna Kleiboeker, Kerry Goldrosen, Lucas Schulz, John P. Rice, Jon S. Odorico, Didier A. Mandelbrot, Jeannina A. Smith, Christopher M. Saddler
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(5)
Antimicrobial stewardship programs (ASPs) are essential entities that promote the appropriate use of antimicrobials, leading to improved patient outcomes and reduced resistance. Application to the immunocompromised host is a natural progression for e
Autor:
Robert R. Redfield, Jeannina A. Smith, Lucas T Schulz, Christopher M. Saddler, Didier A. Mandelbrot, John P. Rice, Margaret R. Jorgenson, Jillian L. Descourouez, Kerry A Goldrosen
Publikováno v:
Infection Control & Hospital Epidemiology. 41:1068-1074
Classical stewardship efforts have targeted immunocompetent patients; however, appropriate use of antimicrobials in the immunocompromised host has become a target of interest. Cytomegalovirus (CMV) infection is one of the most common and significant